Category: Heart failure treatment

New Dilated Cardiomyopathy Study TRED

The Royal Brompton Hosptial Are Seeking DCM Patients for a New Dilated Cardiomyopathy Study TRED Researchers at the Royal Brompton Hospital, and the NHLI (National Heart and Lung Institute) are to begin a new BHF-funded dilated cardiomyopathy study. They are currently inviting patients with a previous DCM diagnosis, whose heart function has recovered after a […]

July 27, 2016

Major Heart Failure Breakthrough

Stem Cell Implants Could Be The Key – Reversing Heart Failure Breakthrough. In a ‘astonishing’ new trial, eleven heart attack patients with stage 3 heart failure, and expected to die withing two years,  are today fit and healthy after scientists regenerated their damaged hearts with stem cells, in a ground-breaking, heart failure breakthrough, phase IIa, […]

July 24, 2016

Electromechanical hug for the heart

  Electromechanical cardioplasty using a wrapped elasto-conductive epicardial mesh Electromechanical hug for the heart A mesh that wraps around the heart can strengthen a failing heart, a new study shows, in rats Interesting news for Cardiac Resyncronisation Therapy; Jinkyung Park from the Institute for Basic Science in Seoul, South Korea, and colleagues design a soft, elastic […]

July 10, 2016

NHS England Announcement CHD

The Pumping Marvellous Foundation today added the following comment following NHS England Announcement on the fufture of congenital heart disease services, and transfer of selected CHD surgical and interventional cardiology: “Our concerns are for patients and how this will affect them, with increased cost and length of travel” – The Pumping Marvellous Foundation Read the […]

July 8, 2016

St. Jude Expand Heart Failure Portfolio

St. Jude Medical Expand Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies Adding SyncAV™ CRT technology to the company’s comprehensive heart failure offerings provides further advantages to the St. Jude Medical portfolio to support physicians seeking new treatment options for heart failure patients St. […]

June 30, 2016

Anti Diabetes Drug Trials for Heart Disease

New Anti Diabetes Drug Trials launched to determine benefits for Cardiovascular Health Researchers at the University of Dundee have launched a series of projects to determine whether a new class of anti diabetes drug could also be used to treat heart disease. Diabetes and heart disease are frequently seen together and can be a potentially […]

June 27, 2016

MedTech Week: Heart Failure Patient Innovation

For MedTech Week, leader of HF advocacy and the heart failure patient conversation, Nick Hartshorne Evans explains how and why patient-led heart failure communities are driving access to the latest heart failure information, innovations and therapies MedTech Week: How to Enable Access to Innovation in Heart Failure for Patients? QUESTION: As an active leader in […]

June 17, 2016

Treating Heart Failure – Open Letter to The Telegraph

    Nick Hartshorne Evans’ Voices Concern in Open Letter to The Telegraph – Treating Heart Failure Following news from the recent studies about a 36% rise in heart failure hospitalisations in the past decade, Pumping Marvellous founder, Nick Hartshorne Evans’ sends an open letter to The Telegraph raising his concerns about the growth and […]

June 17, 2016

Handheld Pocket Ultrasound for Cardiac Nurses

Detecting fluid retention in patients early is important to prevent their heart failure from getting worse. Nurses who are trained in the use of handheld pocket ultrasound devices can dispense diuretic drugs more precisely. These medications prevent harmful fluid retention in patients with heart failure. Researchers at Levanger Hospital and the Norwegian University of Science […]

May 19, 2016

FDA Approval for new ICDs

Medtronic’s ICDs with Atrial Fibrillation Detection Win FDA Approval Medtronic plc today announced it has received U.S. Food and Drug Administration, FDA approval for the Visia AF MRI(TM) SureScan® and Visia AF(TM) single-chamber implantable cardioverter defibrillators (ICDs). The Visia AF devices can detect previously undiagnosed and/or asymptomatic atrial fibrillation (AF) and monitor recurrent AF, while […]

May 5, 2016

NICE Publish Guidance for Sacubitril Valsartan

NICE Publish Guidance for Sacubitril valsartan NICE gives green light to new heart failure drug set to benefit 100,000 people with common heart condition In guidance published today NICE has recommended new heart failure drug sacubitril valsartan (Entresto, Novartis), the first drug of its kind, as an option for some people with heart failure. The […]

April 27, 2016

NICE says ‘Yes’ to heart failure medicine Entresto sacubitril valsartan

NICE says ‘Yes’ to new heart failure medicine, Entresto™ (sacubitril/valsartan), in final recommendation * NICE recognises Entresto sacubitril valsartan as an innovative and cost-effective treatment in the management of symptomatic chronic heart failure with reduced ejection fraction * Heart failure affects around 550,000 people in the UK and has a poor prognosis for many patients, […]

March 18, 2016

NICE Publish Final Appraisal Determination for Sacubitril valsartan for treating symptomatic chronic heart failure

NICE Publish Final Appraisal Determination for Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction National Institute for Health and Care Excellence (NICE) Recommendations in Final Appraisal Determination for Sacubitril valsartan Recommendations 1.1 Sacubitril valsartan is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction, only in people:  […]

March 18, 2016

Sacubitril valsartan – Entresto™ – accepted for use in Scotland by SMC

Novartis’ new heart failure medicine, Entresto™, sacubitril valsartan accepted for use in Scotland by the Scottish Medicines Consortium  SMC recognised sacubitril valsartan represents a new therapeutic option for adult patients with symptomatic chronic heart failure with reduced ejection fraction1and may be used instead of the current gold standard treatment for the condition  Heart […]

March 7, 2016

Trials for First Transcatheter Implant for Diastolic Heart Failure Underway

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure  For the first time in the U.S., a clinical trial is underway that’s evaluating a transcatheter implant device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center. Diastolic […]

February 26, 2016